PROGNOSIS OF SKIP N2 NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
作者：
Chang, Y. [1 ]
Cho, D. [1 ]
Choi, S. [1 ]
机构：
[1] St Vincent Hosp Korea, Thorac & Cardiovasc Surg, Suwon, South Korea
来源：
CHEST | 2020年 / 157卷 / 06期
关键词：
lung cancer; skip N2;
D O I：
10.1016/j.chest.2020.05.027
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：23A / 23A
页数：1
相关论文
共 50 条
  • [1] N2 institutional consensus on Non-Small Cell Lung Cancer (NSCLC)
    Eid, H.
    El Kik, A.
    Karam, E.
    Chamaa, A.
    Habr, B.
    El Karak, F.
    Kourie, H.
    Azouri, F.
    Smayra, V.
    Aoun, N.
    Kattan, J.
    Chahine, G.
    Ghosn, M.
    Wakim, J.
    Nasserddine, H.
    Nasr, F.
    Khayat, G.
    Nakad, J.
    Harmouche, C.
    Dabar, G.
    Tabet, G.
    Aoun, Z.
    Riachy, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Prognostic Factors in Pathologic N2 Non-Small Cell Lung Cancer
    Kim, Hye-Seon
    Cho, Sukki
    Kim, Kwhanmien
    Jheon, Sanghoon
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S578 - S578
  • [3] The Role of Surgery for Treating Occult N2 Non-Small Cell Lung Cancer
    Yanada, Masashi
    Matsuura, Yoshiaki
    Inoue, Masayoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S867 - S868
  • [4] Should we operate on microscopic N2 non-small cell lung cancer?
    Fontaine, Eustace
    McShane, James
    Carr, Martyn
    Shackcloth, Michael
    Mediratta, Neeraj
    Page, Richard
    Poullis, Michael
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (06) : 956 - 961
  • [5] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [6] Survival impact of unexpected N2 in stage IIIB/N2 non-small cell lung cancer patients
    Erdogu, Volkan
    Citak, Necati
    Sezen, Celal Bugra
    Kizir, Dilekhan
    Tanrikulu, Gamze
    Dogru, Mustafa Vedat
    Seyrek, Yunus
    Cansever, Levent
    Saydam, Ozkan
    Metin, Muzaffer
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (03) : 238 - 243
  • [7] Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer
    Misthos, P
    Sepsas, E
    Athanassiadi, K
    Kakaris, S
    Skottis, I
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (04) : 502 - 508
  • [8] Current Surgical Therapy for Stage IIIA (N2) Non-Small Cell Lung Cancer
    Yanagawa, Jane
    Rusch, Valerie W.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2011, 23 (04) : 291 - 296
  • [9] ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer
    Christelle Clément-Duchêne
    Annals of Surgical Oncology, 2018, 25 : 944 - 945
  • [10] Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer
    Van Schil, Paul E.
    Yogeswaran, Krishan
    Hendriks, Jeroen M.
    Lauwers, Patrick
    Faivre-Finn, Corinne
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (06) : 555 - 561
12345